Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Posh Chemicals Private Limited
WARNING LETTER
•Posh Chemicals Private Limited•March 8, 2013

Posh Chemicals Private Limited – FDA Warning Letter, Mar 8, 2013

Record Details

On August 2, 2013, the FDA issued a Warning Letter to Posh Chemicals Private Limited following a March 3-8, 2013 inspection of their pharmaceutical manufacturing facility in Hyderabad, India. The inspection revealed significant deviations from current Good Manufacturing Practice (CGMP) for Active Pharmaceutical Ingredients (APIs), rendering their APIs adulterated under Section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act.

Key violations included: 1. **Failure to protect computerized data:** No restrictions on access to laboratory data on standalone instrumentation (HPLCs, FTIR, GC), allowing alteration or deletion without audit trails. The firm claimed to be updating software but denied misconduct, despite investigator findings. 2. **Non-validated test procedures:** Use of non-validated assays for testing key starting materials and an intermediate in API manufacture. 3. **Failure to follow and document quality-related activities:** A QC Chemist admitted to recording false visual examination data in reserve sample logbooks under a senior colleague's direction. The firm also failed to note a trend of decreasing total impurity results in stability tests for an API.

The FDA requires a detailed summary of investigations into misconduct, data falsification, and the role of the senior colleague, along with plans for a thorough data integrity investigation across all personnel. The firm must submit method validation reports for all non-compendial analytical methods and a timeline

Company
Posh Chemicals Private Limited
Inspection date
March 8, 2013
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Michael D. Smedley
View Company Profile

ID · 1b0d6d0c-b01c-40c7-8850-e3cd7389db39

Violation Codes7
21 U.S.C. 356C(a)(1)21 U.S.C. 381(a)(3)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Posh Chemicals Private Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.